X05233B
Destruction Thoracic Sympathetic Nerve, Cardiac Plexus to New Technology Group 11 with Radiofrequency Ablation, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 0 Nervous System |
| Operation | 5 Destruction |
| Body Part | 2 Thoracic Sympathetic Nerve, Cardiac Plexus |
| Approach | 3 Percutaneous |
| Device | 3 Radiofrequency Ablation |
| Qualifier | B New Technology Group 11 |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
This family covers newer, technologically distinct methods of destroying targeted nervous system tissue, typically portions of brain tissue, using energy-based approaches that differ meaningfully from older destruction techniques already captured elsewhere in ICD-10-PCS. These procedures are most often used to treat conditions such as movement disorders, certain seizure foci, or other neurological conditions where a small, precisely targeted area of tissue is eradicated to relieve symptoms, without physically removing that tissue from the body.
Because these procedures rely on emerging technology, such as image-guided thermal or focused energy systems, they are tracked separately from standard destruction codes so that hospitals and payers can monitor the use, cost, and outcomes of new devices before they become standard practice. Patients typically undergo these procedures in a specialized neurology or neurosurgery setting, often guided by real-time imaging to confirm the treatment is limited to the intended target and spares surrounding healthy tissue.
Anatomy & Axis Detail
Thoracic Sympathetic Nerve, Cardiac Plexus
The thoracic sympathetic chain and cardiac plexus form part of the autonomic network that modulates heart rate, contractility, and abnormal electrical signaling, and selective destruction of these fibers is used in patients with refractory ventricular arrhythmias or electrical storm who have not responded to antiarrhythmic drugs or catheter ablation of the arrhythmia substrate itself. The procedure interrupts sympathetic outflow to the heart, reducing the triggering input that sustains life-threatening rhythm disturbances, and may be performed surgically or through targeted energy delivery near the cardiac plexus and thoracic ganglia. Because this structure sits close to major thoracic vessels, lung, and other mediastinal structures, precise localization is critical, and documentation should specify the approach and confirm the target as the sympathetic supply to the heart rather than a peripheral nerve elsewhere in the thorax.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Radiofrequency Ablation
Radiofrequency Ablation identifies use of a device that delivers radiofrequency electrical current to generate heat and destroy targeted tissue, commonly applied to tumors or aberrant conduction pathways. It is grouped under New Technology to capture novel applications of this energy source. It is distinguished from Ultrasound Ablation by its use of electrical current rather than acoustic energy to achieve tissue destruction.
Qualifier: New Technology Group 11
This qualifier designates Group 11, the most recent cohort at the time of its introduction, grouping technologies newly approved for New Technology section reporting in that fiscal year. Like every group value in this axis, it functions as an administrative marker rather than a description of the clinical intervention, which is captured elsewhere in the code. Its main point of confusion is with Group 10, the immediately preceding annual release.
Coding & Documentation
Assigning a code from this family requires documentation identifying the specific new technology or device used to destroy the tissue, since New Technology section codes are tied to a particular approved technology rather than a general technique. The operative note should describe the target location within the nervous system, confirm that tissue was destroyed in place rather than excised, and reference the specific energy modality or system involved. A frequent error is defaulting to a standard Medical and Surgical section destruction code when the technology actually qualifies for a New Technology code, or vice versa, applying a New Technology code when the device used does not match the approved technology tied to that code.
Commonly Confused With
This family is easily confused with standard Destruction codes in the Medical and Surgical section's Central Nervous System body system, which cover the same root operation concept but use conventional, previously established techniques. It can also be confused with Excision or Resection, which involve physically removing tissue rather than eradicating it in place, and with Ablation-type procedures documented under different terminology; coders should verify whether tissue was removed from the body or destroyed without removal before assigning either root operation.